key: cord-0714208-qflk436p
authors: Lee, Chang Yeol; Degani, Ismail; Cheong, Jiyong; Lee, Jae-Hyun; Choi, Hyun-Jung; Cheon, Jinwoo; Lee, Hakho
title: Fluorescence polarization system for rapid COVID-19 diagnosis
date: 2021-04-15
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2021.113049
sha: a0a2ae97331712677cb35c60fb9b4f2ad94fca66
doc_id: 714208
cord_uid: qflk436p

Prompt diagnosis, patient isolation, and contact tracing are key measures to contain the coronavirus disease 2019 (COVID-19). Molecular tests are the current gold standard for COVID-19 detection, but are carried out at central laboratories, delaying treatment and control decisions. Here we describe a portable assay system for rapid, onsite COVID-19 diagnosis. Termed CODA (CRISPR Optical Detection of Anisotropy), the method combined isothermal nucleic acid amplification, activation of CRISPR/Cas12a, and signal generation in a single assay, eliminating extra manual steps. Importantly, signal detection was based on the ratiometric measurement of fluorescent anisotropy, which allowed CODA to achieve a high signal-to-noise ratio. For point-of-care operation, we built a compact, standalone CODA device integrating optoelectronics, an embedded heater, and a microcontroller for data processing. The developed system completed SARS-CoV-2 RNA detection within 20 min of sample loading; the limit of detection reached 3 copy/μL. When applied to clinical samples (10 confirmed COVID-19 patients; 10 controls), the rapid CODA test accurately classified COVID-19 status, in concordance with gold-standard clinical diagnostics.

. Real-time user interface. At the far left is a configuration panel where experimental parameters can be tuned, including (i) the number of measurements to collect, (ii) how long each measurement should take, and (iii) how many samplings to average in order to obtain a reliable measurement. The reference fluorescence anisotropy (FA) value (r0) can also be set here. The main dashboard is divided into four quadrants, where the user can monitor the raw fluorescent intensity for both parallel and perpendicular FA detectors (upper left), as well as a continuously computed FA value (lower left). Temperature and PID control signals are continuously monitored (upper right) and multiple patient samples can be analyzed sequentially in a batch and plotted (lower right). The dashboard is shown running on Windows 7-64 bit, though it is fully cross-platform and can run on a variety of operating systems that support the Qt GUI toolkit (MacOS/Linux). In step 1, fluorescence intensity data from parallel (red) and perpendicular (blue) channels are captured as 14-bit integers every 0.1 sec. These signals may contain common noise (orange arrows). The channels are then subtracted, normalized, and scaled by factor F, leading to the continuous anisotropy plot of step 2. Note that the anisotropy measurement is free of the common noise fluctuations. A rolling standard deviation of the most recent 40 anisotropy samplings is monitored during data collection to ensure that the values are stable. Finally, in step 3, a measurement is taken as the average of 40 samples, provided that their standard deviation is less than 0.5%. The length of the reporter probe was varied and the resulting anisotropy signal from CRISPR cleavage was measured. The optimal length was found to be 9 bases. (b) The concentration of the 9-base probe was optimized to achieve the maximal anisotropy signal. The optimal concentration was found to be 0.1 µM. The target concentration (SARS-CoV-2 plasmid control) was fixed at 10 3 copy/µL. All experiments were performed in triplicate and the data are displayed as means ± s.e.m. (a) The colors of oligonucleotide sequences correspond to those of the domains depicted in Fig. 1(a) . (b) Underlined sequence is a T7 promoter sequence. 

Dual-functional plasmic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection

Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone

US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform

Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)

Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2

INSIGHT: a population scale COVID-19 testing strategy combining point-of-care diagnosis with centralised high-throughput sequencing

CRISPR-Cas12-based detection of SARS-CoV-2

Ultra-sensitive and high-throughput CRISPR-powered COVID-19 diagnosis